[HTML][HTML] The genetics of monogenic intestinal epithelial disorders

SJ Babcock, D Flores-Marin, JR Thiagarajah - Human Genetics, 2023 - Springer
SJ Babcock, D Flores-Marin, JR Thiagarajah
Human Genetics, 2023Springer
Monogenic intestinal epithelial disorders, also known as congenital diarrheas and
enteropathies (CoDEs), are a group of rare diseases that result from mutations in genes that
primarily affect intestinal epithelial cell function. Patients with CoDE disorders generally
present with infantile-onset diarrhea and poor growth, and often require intensive fluid and
nutritional management. CoDE disorders can be classified into several categories that relate
to broad areas of epithelial function, structure, and development. The advent of accessible …
Abstract
Monogenic intestinal epithelial disorders, also known as congenital diarrheas and enteropathies (CoDEs), are a group of rare diseases that result from mutations in genes that primarily affect intestinal epithelial cell function. Patients with CoDE disorders generally present with infantile-onset diarrhea and poor growth, and often require intensive fluid and nutritional management. CoDE disorders can be classified into several categories that relate to broad areas of epithelial function, structure, and development. The advent of accessible and low-cost genetic sequencing has accelerated discovery in the field with over 45 different genes now associated with CoDE disorders. Despite this increasing knowledge in the causal genetics of disease, the underlying cellular pathophysiology remains incompletely understood for many disorders. Consequently, clinical management options for CoDE disorders are currently limited and there is an urgent need for new and disorder-specific therapies. In this review, we provide a general overview of CoDE disorders, including a historical perspective of the field and relationship to other monogenic disorders of the intestine. We describe the genetics, clinical presentation, and known pathophysiology for specific disorders. Lastly, we describe the major challenges relating to CoDE disorders, briefly outline key areas that need further study, and provide a perspective on the future genetic and therapeutic landscape.
Springer